Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.59 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.59 |
| ▸ | MAPT | P10636 | 1/20 | 0.52 |
| ▸ | LCK | P06239 | 1/20 | 0.52 |
| ▸ | PPARD | Q03181 | 1/20 | 0.52 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.52 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.52 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.45 |
| ▸ | GRIK1 | P39086 | 2/20 | 0.44 |
| ▸ | GRIK2 | Q13002 | 2/20 | 0.44 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.44 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.42 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.42 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.41 |
| ▸ | BLM | P54132 | 1/20 | 0.41 |
| ▸ | HSPE1 | P61604 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17255855 | 1.00 | GPR84 (0.59) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL7750264 | 1.00 | GPR84 (0.59) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL8744934 | 0.92 | HSD17B10 (0.51) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL17244841 | 0.88 | GPR84 (0.53) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL9108501 | 0.86 | GPR84 (0.52) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL8856265 | 0.86 | GPR84 (0.52) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL8208596 | 0.86 | GPR84 (0.52) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL8856129 | 0.86 | GPR84 (0.52) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL8856116 | 0.86 | GPR84 (0.52) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL11344216 | 0.86 | GPR84 (0.52) | GPR84FFAR1MAPTLCKPPARD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3962917-A1 | METHOD FOR THE MANUFACTURE OF ALKOXYSILYL-CONTAINING THIOCARBOXYLIC ACID ESTERS | Momentive Performance Materials Inc. (US) | 2022-03-09 | — | — | EP | claimed |
| CN-113795499-A | Process for producing alkoxysilyl group-containing thiocarboxylic ester | 迈图高新材料公司 | 2021-12-14 | — | — | CN | claimed |
| EP-3884018-A1 | JASMOL | Symrise AG (DE) | 2021-09-29 | — | — | EP | claimed |
| US-10919920-B2 | Method for the manufacture of alkoxysilyl-containing thiocarboxylic acid esters | MOMENTIVE PERFORMANCE MATERIALS INC. (US) | 2021-02-16 | — | — | US | claimed |
| US-20200347084-A1 | METHOD FOR THE MANUFACTURE OF ALKOXYSILYL-CONTAINING THIOCARBOXYLIC ACID ESTERS | MOMENTIVE PERFORMANCE MATERIALS INC. | 2020-11-05 | — | — | US | claimed |
| WO-2020223068-A1 | METHOD FOR THE MANUFACTURE OF ALKOXYSILYL-CONTAINING THIOCARBOXYLIC ACID ESTERS | MOMENTIVE PERFORMANCE MATERIALS INC. (US) | 2020-11-05 | — | — | WO | claimed |
| EP-3962917-A1 | METHOD FOR THE MANUFACTURE OF ALKOXYSILYL-CONTAINING THIOCARBOXYLIC ACID ESTERS | Momentive Performance Materials Inc. (US) | 2022-03-09 | — | — | EP | disclosed |
| CN-113795499-A | Process for producing alkoxysilyl group-containing thiocarboxylic ester | 迈图高新材料公司 | 2021-12-14 | — | — | CN | disclosed |
| EP-3884018-A1 | JASMOL | Symrise AG (DE) | 2021-09-29 | — | — | EP | disclosed |
| US-10919920-B2 | Method for the manufacture of alkoxysilyl-containing thiocarboxylic acid esters | MOMENTIVE PERFORMANCE MATERIALS INC. (US) | 2021-02-16 | — | — | US | disclosed |
| US-20200347084-A1 | METHOD FOR THE MANUFACTURE OF ALKOXYSILYL-CONTAINING THIOCARBOXYLIC ACID ESTERS | MOMENTIVE PERFORMANCE MATERIALS INC. | 2020-11-05 | — | — | US | disclosed |
| WO-2020223068-A1 | METHOD FOR THE MANUFACTURE OF ALKOXYSILYL-CONTAINING THIOCARBOXYLIC ACID ESTERS | MOMENTIVE PERFORMANCE MATERIALS INC. (US) | 2020-11-05 | — | — | WO | disclosed |
| WO-2017046058-A1 | PERFUME COMPOSITION HAVING ODOR MODULATOR COMPOUNDS FOR INCREASING ODOR INTENSITY | HENKEL AG & CO. KGAA (DE) | 2017-03-23 | — | — | WO | disclosed |
| EP-0871620-A4 | BIOCATALYTIC METHODS FOR SYNTHESIZING AND IDENTIFYING BIOLOGICALLY ACTIVE COMPOUNDS | ENZYMED INC (US) | 1999-10-27 | — | — | EP | disclosed |
| EP-0871620-A1 | BIOCATALYTIC METHODS FOR SYNTHESIZING AND IDENTIFYING BIOLOGICALLY ACTIVE COMPOUNDS | ENZYMED, Inc. (US) | 1998-10-21 | — | — | EP | disclosed |
| WO-1997010233-A9 | BIOCATALYTIC METHODS FOR SYNTHESIZING AND IDENTIFYING BIOLOGICALLY ACTIVE COMPOUNDS | — | 1997-05-09 | — | — | WO | disclosed |
| WO-1997010233-A1 | BIOCATALYTIC METHODS FOR SYNTHESIZING AND IDENTIFYING BIOLOGICALLY ACTIVE COMPOUNDS | ENZYMED, INC. (US) | 1997-03-20 | — | — | WO | disclosed |
| WO-1996005511-A1 | BIOCATALYTIC METHODS FOR SYNTHESIZING AND IDENTIFYING BIOLOGICALLY ACTIVE COMPOUNDS | ENZYMED, INC. (US) | 1996-02-22 | — | — | WO | disclosed |
| EP-0576287-A1 | Cosmetic compositions | UNILEVER PLC (GB) | 1993-12-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10919920-B2 | Method for the manufacture of alkoxysilyl-containing thiocarboxylic acid esters | TST, MPST, APEH | GPR84 4409/4885FFAR1 2684/4885MAPT 3621/4885 |
| US-20200347084-A1 | METHOD FOR THE MANUFACTURE OF ALKOXYSILYL-CONTAINING THIOCARBOXYLIC ACID ESTERS | TST, MPST, APEH | GPR84 4409/4885FFAR1 2684/4885MAPT 3621/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.